相关实验视频

Updated: Jul 12, 2026

Principles of Site-Specific Recombinase (SSR) Technology
07:06

Principles of Site-Specific Recombinase (SSR) Technology

Published on: May 29, 2008

"这不是秘密 - 这不是广告" - 内容,格式和平台偏好,以促进在美国南部的PrEP使用

Ronnie M Gravett1, Joseph D Tucker2,3, Lynn T Matthews4

  • 1Division of Infectious Diseases, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, 1900 University Blvd, THT 225, Birmingham, AL, 35294, USA. rgravett@uabmc.edu.

AIDS and behavior
|January 18, 2026
PubMed
概括

美国南部的同性恋,双性恋和其他与男性发生性关系的男性 (GBM) 需要更好的艾滋病毒暴露前预防 (PrEP) 宣传. 专注于获取,安全和谨慎交付的数字内容是提高PrEP吸收的首选.

关键词:
艾滋病毒暴露前预防 暴露前预防促进健康 促进健康与男性发生性关系的男性.定性研究是一种定性研究.

更多相关视频

Preparation and Testing of Plant Seed Meal-based Wood Adhesives08:09

Preparation and Testing of Plant Seed Meal-based Wood Adhesives

Published on: March 5, 2015

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

相关概念视频

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
Southern Blot02:57

Southern Blot

Agarose gel electrophoresis is very useful in separating DNA fragments by size. Running a DNA ladder containing fragments of the known length alongside the sample helps determine the approximate length of the sample DNA fragments. However, additional steps are needed to verify the sequence identity of the sample DNA fragments.
Denatured DNA fragments must be transferred onto a carrier membrane from the gel to make it accessible to a probe - a small ssDNA fragment complementary to the target DNA...
Preparation of Amides01:29

Preparation of Amides

Amides are synthesized by treating carboxylic acids with amines in the presence of dehydrating agents like dicyclohexylcarbodiimide (DCC).
The DCC-promoted synthesis of amides begins with the protonation of DCC by carboxylic acid. The protonation makes it a better acceptor. Next, the addition of carboxylate to the protonated carbodiimide gives a reactive acylating agent.
Subsequently, the amine acts as a nucleophile that attacks the acylating agent to form a tetrahedral intermediate. In the...
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...